Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Fischl

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
JAMA|January 18, 1985
Mothers of infants with the acquired immunodeficiency syndrome. Evidence for both symptomatic and asymptomatic carriersG B Scott, M A Fischl, N Klimas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1994
Nocardiosis in 30 patients with advanced human immunodeficiency virus infection: clinical features and outcomeR B Uttamchandani, G L Daikos, R R Reyes, et al.
Annals of Internal Medicine|June 15, 1992
Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. The AIDS Clinical Trials GroupR D Gelber, W R Lenderking, D J Cotton, et al.
Journal of the American Academy of Dermatology|October 1, 1993
An evaluation of oral ulcers in patients with AIDS and AIDS-related complexG S Liang, G L Daikos, U Serfling, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1996
Didanosine reduces atevirdine absorption in subjects with human immunodeficiency virus infectionsG D Morse, M A Fischl, M J Shelton, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|May 1, 1997
Phase I/II study of the toxicity, pharmacokinetics, and activity of the HIV protease inhibitor SC-52151M A Fischl, D D Richman, C Flexner, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 1, 1995
Combination therapy with recombinant human soluble CD4-immunoglobulin G and zidovudine in patients with HIV infection: a phase I studyT C Meng, M A Fischl, S H Cheeseman, et al.
Lancet (London, England)|January 17, 1987
Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidineR Yarchoan, G Berg, P Brouwers, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2000
Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260)L M Demeter, R W Shafer, P M Meehan, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcomaM A Fischl, R B Uttamchandani, L Resnick, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
JAMA|January 18, 1985
Mothers of infants with the acquired immunodeficiency syndrome. Evidence for both symptomatic and asymptomatic carriersG B Scott, M A Fischl, N Klimas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1994
Nocardiosis in 30 patients with advanced human immunodeficiency virus infection: clinical features and outcomeR B Uttamchandani, G L Daikos, R R Reyes, et al.
Annals of Internal Medicine|June 15, 1992
Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. The AIDS Clinical Trials GroupR D Gelber, W R Lenderking, D J Cotton, et al.
Journal of the American Academy of Dermatology|October 1, 1993
An evaluation of oral ulcers in patients with AIDS and AIDS-related complexG S Liang, G L Daikos, U Serfling, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1996
Didanosine reduces atevirdine absorption in subjects with human immunodeficiency virus infectionsG D Morse, M A Fischl, M J Shelton, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|May 1, 1997
Phase I/II study of the toxicity, pharmacokinetics, and activity of the HIV protease inhibitor SC-52151M A Fischl, D D Richman, C Flexner, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 1, 1995
Combination therapy with recombinant human soluble CD4-immunoglobulin G and zidovudine in patients with HIV infection: a phase I studyT C Meng, M A Fischl, S H Cheeseman, et al.
Lancet (London, England)|January 17, 1987
Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidineR Yarchoan, G Berg, P Brouwers, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2000
Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260)L M Demeter, R W Shafer, P M Meehan, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcomaM A Fischl, R B Uttamchandani, L Resnick, et al.
Pageof 11